Bariatric Surgery Perspective

 
 
  • 11 More Highlights From Digestive Disease Week 2023   Dr David Johnson offers yet more practice-changing observations from this year's meeting, which featured an abundance of data on novel treatments and new revelations about established interventions.
  • Does Ozempic Cause Hair Loss? Dermatologists and endocrinologists consider claims that new weight loss medications cause hair loss. They opine that hair loss is unlikely and is actually more common with bariatric surgery.
  • S2 Episode 5: Weight Management as a Goal in Type 2 Diabetes Care   Join Drs Carol Wysham and Carel le Roux for practical, actionable strategies when targeting weight management as a key goal in type 2 diabetes prevention and treatment.
  • Kid’s Health Improves by Applying New Obesity Guidelines New guidelines call for options, including lifestyle changes, medication use, and bariatric surgery in children. This case study provides insight into applying them in a real-life clinical setting.
  • Episode 2: Obesity as a Disease: Changing the Paradigm   How to change the paradigm on obesity as a disease? In this episode, Drs Robert Kushner and Donna Ryan dig into the science, speak about bias in the healthcare system, and advocate for better patient care.
  • New Antiobesity Drugs Will Benefit Many. Is That Bad? New antiobesity medicines are being deemed too costly for insurers despite the success patients have had with losing weight and improving their health. Dr Yoni Freedhoff ponders why.
  • Will New Guidelines Widen the Gap in Treating Kids' Obesity? The new AAP guidelines advocating for "aggressive" treatment in managing obesity in kids may only further widen the gap between the "haves and have-nots," argues Liliana Aguayo.
  • What's It Like to Take Ozempic? A Doctor's Own Story With the rising popularity of weight loss drug injections, you may be getting many more questions from patients. Here, a doctor shares her own experience of taking these medications.
  • AAP vs AED on Obesity Treatment: Is There a Middle Ground? While the guidelines certainly don't urge the use of medications or surgery as first-line treatment, the new recommendations do put them on the table as options.
  • Tips for Maximizing Colonoscopy Preps   Dr David Johnson shares some simple strategies for improving your patients' experience around the aspect of colonoscopy that they often dread the most.
  • Commenting on Weight's Not Rude. It's Dangerous. Making comments about a patient's weight can be seen as bias. Dr Gonsahn-Bollie gives advice on how to talk about weight with patients.
  • Weight Bias Affects Views of Kids' Obesity Recommendations New recommendations for "aggressive treatment" for children with obesity have sparked outrage among many. Dr Yoni Freedhoff says the extreme reaction doesn't surprise him but is unwarranted.
  • Can New Growth Charts Curb the Pediatric Obesity Epidemic? Newly revised CDC growth charts address flaws in the 2000 version, but Justin Ryder, PhD, explains why it’s not enough to address the pediatric obesity crisis.
  • Jan 6 2023 This Week in Cardiology   Damar Hamlin, obesity and semaglutide, Open Data and PCSK9 inhibitors, and TAVI vs SAVR trials are the topics John Mandrola, MD, discusses in this week’s podcast.
  • The New Obesity Breakthrough Drugs I'm not using the term breakthrough lightly.
  • Bariatric Surgery Reduces Obesity-Related Cancer Risk   Maurie Markman, MD, discusses results from a case-control study of individuals with high BMI, demonstrating reduced obesity-related cancer risk following bariatric surgery.
  • New Indications for Bariatric Surgery: My Reservations   It's great having updated recommendations for bariatric surgery, but they fail to take new effective weight loss drugs into account, says Dr Neil Skolnik.
  • ACG 2022 Read clinically focused news coverage of key developments from ACG 2022
  • Accepting Obesity Shouldn't Stop Us From Warning of Its Dangers   A bioethicist says overweight people need emotional support and acceptance, but clinicians should not stop conveying that obesity is a dangerous disease.
  • Remission Is a Worthy Goal in Type 2 Diabetes Dr Robert Gabbay, chief medical officer of the American Diabetes Association, explains why remission, not reversal, needs to be the goal for type 2 diabetes.